GSK enters epigenetics space with Cellzome alliance
10 March 2010
Sukaina Virji
Please Login to read the full article.
10 March 2010
Sukaina Virji
sukaina.virji@informa.com
Cellzome has entered a strategic alliance with GlaxoSmithKline giving the big pharma company exclusive access to its epigenetics-based platform Episphere for drug discovery in the field of immuno-inflammatory disease.
The financial terms include an upfront payment of €33 million to...
Please Login to read the full article.
RELATED CONTENT
FEATURES
- Merck BioVentures: where biosimilars make a difference
- Chinese producers may be losing price edge to India, says Granules MD
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
